New production line for medical engineering products

Plansee is investing ten million euros in the construction of a new production line for medical engineering products. The official launch of this largest single investment at the Breitenwang/Reutte site in 2017 took place today in the presence of Austrian Chancellor Christian Kern.

Photo: Dr. Andreas Lackner (Executive Director Plansee SE) explains Chancellor Kern the role of our components in modern medical devices

Plansee's largest production site, Reutte, has already been manufacturing medical engineering products for over 60 years. The components are installed in X-ray machines and CT scanners. What is new is that Plansee is setting up a highly automated, networked production line that can meet the demands of Industry 4.0. The new production line should be fully installed within 12 months.

“We want to continue to produce medical engineering products highly competitively in the heart of Europe in the years to come,” explains Bernhard Schretter, member of the Board of Directors of Plansee Holding AG. Intelligent interfaces, end-to-end product coding and tight processes will permit considerably shorter delivery times.

In total, Plansee and Ceratizit invested 46 million euros in the Breitenwang/Reutte site in the last financial year 2016/17. Investments on a similar scale are planned for the current year. Of the 2,270 employees working at the site, 25 percent play a specialist role. In order to meet its need for specialist staff as far as possible from internal sources, the company continually trains some 130 apprentices in 6 different fields.